Literature DB >> 25690172

CORR Insights(®): The Alpha-defensin Test for Periprosthetic Joint Infection Responds to a Wide Spectrum of Organisms.

Bryan D Springer1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25690172      PMCID： PMC4457744          DOI： 10.1007/s11999-015-4198-9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  5 in total

1.  Consensus statement from the International Consensus Meeting on Periprosthetic Joint Infection.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2013-10-11       Impact factor: 4.176

2.  International consensus on periprosthetic joint infection: description of the consensus process.

Authors:  William Cats-Baril; Thorsten Gehrke; Katherine Huff; Daniel Kendoff; Mitchell Maltenfort; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2013-10-24       Impact factor: 4.176

3.  The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty.

Authors:  Joshua Bingham; Henry Clarke; Mark Spangehl; Adam Schwartz; Christopher Beauchamp; Brynn Goldberg
Journal:  Clin Orthop Relat Res       Date:  2014-09-26       Impact factor: 4.176

4.  Combined measurement of synovial fluid α-Defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection.

Authors:  Carl Deirmengian; Keith Kardos; Patrick Kilmartin; Alexander Cameron; Kevin Schiller; Javad Parvizi
Journal:  J Bone Joint Surg Am       Date:  2014-09-03       Impact factor: 5.284

5.  Diagnosing periprosthetic joint infection: has the era of the biomarker arrived?

Authors:  Carl Deirmengian; Keith Kardos; Patrick Kilmartin; Alexander Cameron; Kevin Schiller; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-11       Impact factor: 4.176
  5 in total
  1 in total

1.  How Reliable Is the Alpha-defensin Immunoassay Test for Diagnosing Periprosthetic Joint Infection? A Prospective Study.

Authors:  Tommaso Bonanzinga; Akos Zahar; Michael Dütsch; Christian Lausmann; Daniel Kendoff; Thorsten Gehrke
Journal:  Clin Orthop Relat Res       Date:  2017-02       Impact factor: 4.176
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.